Literature DB >> 20026253

Acute noxious stimulation modifies morphine effect in serotonergic but not dopaminergic midbrain areas.

D Bajic1, K G Commons.   

Abstract

It is poorly understood if and how pain may modify the effect of opioids on neural systems that contribute to reward and addictive behavior. We hypothesized that the activation of ascending dopaminergic and serotonergic nuclei by morphine is modified by the presence of noxious stimulation. Immunohistochemical double-labeling technique with Fos was used to examine if an intraplantar formalin injection, an acute noxious input, changed the effect of morphine on dopaminergic neurons of the ventral tegmental area (VTA), and serotonergic neurons of the dorsal raphe nucleus (DR). Four groups of rats were analyzed: (1) control injected with normal saline s.c., (2) rats treated with formalin into the hind paw 30 min after normal saline injection, (3) rats injected with morphine sulfate s.c., and (4) rats treated with formalin into the hind paw 30 min after morphine injection (morphine/formalin). Following morphine injection, there was an increase in the number of dopaminergic neurons in the VTA with Fos immunolabeling. However, noxious stimulation did not detectably change morphine's effect on Fos expression in VTA dopamine neurons. In contrast, the number of serotonergic neurons containing Fos was increased in the morphine/formalin group compared to all other groups and this effect was topographically selective for the dorsal area of the DR at mid rostro-caudal levels. Therefore, morphine's activation of the VTA, which is associated with motivated behavior and reward seeking, appears similar in the context of pain. However, activation of the ascending serotonin system, which influences mood and has the capacity to modify reward pathways, appears different. In addition, these findings reveal interactions between nociceptive signaling and opioids that contrasts with the notion that opioids simply block access of nociceptive signaling to supraspinal structures. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026253      PMCID: PMC2823975          DOI: 10.1016/j.neuroscience.2009.12.031

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  52 in total

Review 1.  Drugs of abuse and the brain.

Authors:  A I Leshner; G F Koob
Journal:  Proc Assoc Am Physicians       Date:  1999 Mar-Apr

2.  Induction of c-fos-like protein in spinal cord neurons following sensory stimulation.

Authors:  S P Hunt; A Pini; G Evan
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

3.  Addiction rare in patients treated with narcotics.

Authors:  J Porter; H Jick
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

4.  Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.

Authors:  R M Hagan; B J Jones; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

5.  Serotoninergic neurons in the brainstem expressing FOS protein after orofacial noxious stimulation: an immunocytochemical double-labeling study.

Authors:  B Lang; Y Q Li
Journal:  J Hirnforsch       Date:  1998

6.  Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat.

Authors:  K Yoshimoto; W J McBride
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

7.  The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.

Authors:  Y Minabe; K Emori; C R Ashby
Journal:  Synapse       Date:  1996-01       Impact factor: 2.562

8.  Drug addiction: functional neurotoxicity of the brain reward systems.

Authors:  F Weiss; G F Koob
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

9.  The formalin test: scoring properties of the first and second phases of the pain response in rats.

Authors:  Frances V Abbott; Keith B J Franklin; Frederick R Westbrook
Journal:  Pain       Date:  1995-01       Impact factor: 6.961

10.  Convergence of deep somatic and visceral nociceptive information onto a discrete ventrolateral midbrain periaqueductal gray region.

Authors:  K A Keay; C I Clement; B Owler; A Depaulis; R Bandler
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

View more
  4 in total

1.  Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle.

Authors:  B M Spannuth; M W Hale; A K Evans; J L Lukkes; S Campeau; C A Lowry
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 2.  Evaluation of reward from pain relief.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Tamara King; Frank Porreca
Journal:  Ann N Y Acad Sci       Date:  2013-03-15       Impact factor: 5.691

Review 3.  The role of microglia in the progression of glaucomatous neurodegeneration- a review.

Authors:  Hui-Lan Zeng; Jing-Ming Shi
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

4.  Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry.

Authors:  Edita Navratilova; Jennifer Y Xie; Alec Okun; Chaoling Qu; Nathan Eyde; Shuang Ci; Michael H Ossipov; Tamara King; Howard L Fields; Frank Porreca
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.